Experience yourself in a new way

Dr. Sidney H. Kennedy is Professor of Psychiatry at the University of Toronto, the Arthur Sommer Rotenberg Chair in Suicide and Depression Studies, and a Scientist at Li Ka Shing Knowledge Institute and Toronto Western Research Institute, Toronto, Canada. Dr. Kennedy is the lead investigator for a large depression biomarker initiative. He has published extensively on new drug evaluation, neuroimaging and neurostimulation therapies, personality factors in depression, antidepressant effects on sexual function and treatment guidelines for Major Depressive Disorder and Bipolar Disorder.Dr. Kennedy is the Immediate Past President of the International Society for Affective Disorders, former President of the Canadian College of Neuropsychopharmacology, and the founding chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT). He has published more than 350 peer reviewed publications and 11 books on depression and related topics.

Dr. Dominique Morisano, CPsych is a licensed clinical psychologist (Ontario, New York), researcher, and adjunct professor. She completed her undergraduate education at Brown University, her MA/PhD at McGill University, a postdoctoral fellowship at CAMH/University of Toronto in Addiction Psychiatry/Schizophrenia, and more recently, a Certificate in Psychedelic-Assisted Therapies and Research at the California Institute for Integral Studies. She holds academic appointments at the Centre for Addiction and Mental Health (CAMH), University of Toronto, and Erasmus University Rotterdam (NL).

Dr. Matthew W. Johnson, Ph.D., Professor at Johns Hopkins University, is an expert on psychedelics, other psychoactive drugs, and addiction. Dr. Johnson has published 119 scientific manuscripts, including 47 manuscripts focused on psychedelics. He has conducted research with psychedelics since 2004, and has conducted experimental research in psychopharmacology since 1996.

David Erritzoe is Clinical Senior Lecturer and Consultant Psychiatrist at Imperial College London and in CNWL Mental Health NHS Foundation Trust. David conducts psychopharmacological research and uses brain imaging techniques such as PET, MRI and EEG to investigate the neurobiology of mental illness. As Clinical Director in the Centre for Psychedelic Research, he investigates mechanisms and therapeutic potential of classic psychedelics and ketamine (trials in depression, OCD, and anorexia nervosa). In early 2021 David also set up a new NHS-based psychopharmacology & psychedelic research clinic at St Charles Hospital in London, named the CIPPRes Clinic.

Dr. Michael Verbora earned an MBA from the Odette School of Business in 2009 and an M.D. from Schulich School of Medicine at Western University in 2013 before entering Family Practice residency at the University of Toronto. He has worked as a leading physician in several clinics and is passionate about furthering knowledge on inner healing intelligence.

Dr. Leora Pinhas is an assistant professor in the Department of Psychiatry at the University of Toronto. She is a graduate of the University of Ottawa Medical School and completed her residency and fellowship at the University of Toronto. She has also completed a masters in epidemiology at the Dalla Lana School of Public Health at the University of Toronto.

Sabina Pillai is a Registered Psychotherapist with an M.A. in Clinical and Counselling Psychology from the University of Toronto. She has spent many years working as a psychotherapist in private clinics and as a researcher and facilitator in mindfulness meditation. She is passionate and knowledgeable about the value psychedelics can bring to clients' lives. Her warm, non-judgemental approach has helped her clients overcome challenges and reach their full potential as human beings.

Martha Kezemidis is a Registered Psychotherapist with the College of Registered Psychotherapists of Ontario (CRPO). Martha is also a Certified Hypnotherapist with the National Guild of Hypnotists, as well as a Certified Yoga Teacher. Her psychotherapeutic approach has a foundation of mindfulness and compassion.

Dr. Ben Medrano is a board-certified psychiatrist who completed his undergraduate education at Naropa University and the University of Colorado at Denver. He attended medical school at the University of Colorado School of Medicine, followed by a residency at Mount Sinai Beth Israel in New York City. His clinical practice is influenced by a lifelong interest in eastern psychology and complementary alternative medicine. These interests are further enhanced by his current fellowship at the Integrative Psychiatry Institute sponsored by the University of Colorado School of Medicine.